Department of Otolaryngology, University of California San Diego, San Diego, California.
Rady Children's Hospital San Diego, San Diego, California.
Hosp Pediatr. 2022 Oct 1;12(10):892-898. doi: 10.1542/hpeds.2022-006567.
To compare the effectiveness of dexamethasone versus prednisone or prednisolone on hospital resource utilization for children hospitalized with acute croup.
This is a retrospective cohort study of the Pediatric Health Information System database on children aged 6 months to <6 years who were hospitalized with acute croup between January 1, 2015 and December 31, 2019. Children with a chronic complex condition, transferred from outside hospital, and/or received direction admission to ICU were excluded. Propensity score matching was used to compare length of stay (in hours), escalation of care to ICU, and the need for bronchoscopy with exposure to dexamethasone versus prednisone or prednisolone. We also compared rates of 7 day return to the emergency department and readmissions.
A total of 11 740 hospitalizations met inclusion criteria; dexamethasone was used in 95.9%; prednisone or prednisolone was used in 4.1%. In the matched cohort (n = 960), the length of stay was not significantly different between the dexamethasone and prednisone or prednisolone groups (21.3 vs 18.5 hours, P = .35). Although the rates bronchoscopy did not differ between the 2 groups, the dexamethasone cohort was more likely to require ICU transfer (P = .007). The rates of 7-day emergency department returns (2.3% vs 1.3%, P = .24) and readmissions (3.1% vs. 2.1%, P = .37) were low and not statistically different.
Hospital resource utilization did not differ significantly for children receiving dexamethasone or prednisone or prednisolone for acute croup. Both corticosteroids may be considered reasonable choices for the treatment of children hospitalized with acute croup.
比较地塞米松与泼尼松龙或泼尼松治疗儿童急性喉炎住院资源利用的效果。
这是一项回顾性队列研究,使用儿科健康信息系统数据库,纳入 2015 年 1 月 1 日至 2019 年 12 月 31 日期间因急性喉炎住院的 6 个月至<6 岁儿童。排除患有慢性复杂疾病、从外院转入和/或被指示收入 ICU 的患儿。采用倾向评分匹配比较地塞米松与泼尼松龙或泼尼松组的住院时间(以小时计)、升级至 ICU 治疗、以及接受支气管镜检查的必要性。我们还比较了 7 天内返回急诊室和再次入院的比例。
共纳入 11740 例符合条件的住院病例;地塞米松使用率为 95.9%,泼尼松龙或泼尼松使用率为 4.1%。在匹配队列(n=960)中,地塞米松组和泼尼松龙或泼尼松组的住院时间无显著差异(21.3 小时比 18.5 小时,P=.35)。尽管两组接受支气管镜检查的比例无差异,但地塞米松组更有可能需要转入 ICU(P=.007)。7 天内返回急诊室(2.3%比 1.3%,P=.24)和再次入院(3.1%比 2.1%,P=.37)的比例较低且无统计学差异。
接受地塞米松或泼尼松龙或泼尼松治疗的儿童的住院资源利用无显著差异。对于因急性喉炎住院的儿童,这两种皮质类固醇都可能是合理的治疗选择。